Prescribing practices in psychiatric hospitals in Eastern Europe

European Psychiatry

Volumn 26, Issue 7, 2011, Pages 414-418

  Jordanova, V ^a   Maric, N P ^b   Alikaj, V ^c   Bajs, M ^d   Cavic, T ^e   Iosub, D ^f   Mihai, A ^g   Szalontay, A ^h   Sartorius, N ⁱ  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^d KBC Zagreb   (Croatia)

^e Institute for Neuropsychiatry Dr Laza Lazarevic   (Serbia)

^f Hospital Centre   (France)

^g UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^h GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

ⁱ UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Evidence based practice; Monotherapy; Patterns; Polypharmacy; Psychotropic prescribing

Indexed keywords

ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ALBANIA; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CROATIA; DEPRESSION; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; MACEDONIA (REPUBLIC); MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD; MENTAL HOSPITAL; MONOTHERAPY; POLYPHARMACY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOSIS; ROMANIA; SERBIA;

ADULT; DRUG UTILIZATION; EUROPE, EASTERN; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MENTAL DISORDERS; MIDDLE AGED; NEEDS ASSESSMENT; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PRESCRIPTION DRUGS; PSYCHOTROPIC DRUGS;

EID: 80053634380     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2010.05.005     Document Type: Article

References (25)

1. British Medical Association & Royal Pharmaceutical Society of Great Britain. British National Formulary. BMJ Books & Pharmaceutical Press; 2005.
2. Centorrino F., Goren J.L., Hennen J., Salvatore P., Kelleher J.P., Baldessarini R.J. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry 2004, 161:700-706.
3. Divac N., Jasovic M., Djukic L., Vujnovic M., Babic M., Bajcetic M. Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia. Pharmacoepidemiol Drug Saf 2004, 13:315-322.
4. Divac N., Jasović-Gasić M., Samardzić R., Lacković M., Prostran M. Antipsychotic polypharmacy at the University Psychiatric Hospital in Serbia. Pharmacoepidemiol Drug Saf 2007, 16:1250-1251.
5. Foster K., Meltzer H., Gill B., Hinds K. The circumstances of adults with a psychotic disorder. Int Rev Psychiatry 2003, 15:84-90.
6. Gater R., Jordanova V., Maric N., Alikaj V., Bajs M., Cavic T., et al. Pathways to psychiatric care in Eastern Europe. Br J Psychiatry 2005, 186:529-535.
7. Hallahan B., Murray I., McDonald C. Benzodiazepine and hypnotic prescribing in an acute adult psychiatric in-patient unit. Psych Bull 2009, 33:12-14.
8. Harrington M. The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the UK. Psych Bull 2002, 26:414-418.
9. Holloway F. Prescribing for the long-term mentally ill. A study of treatment practices. Br J Psychiatry 1988, 152:511-515.
10. Ito H., Koyama A., Higuchi T. Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br J Psychiatry 2005, 187:243-247.
11. Johnson S., Kuhlmann R. The European Service Mapping Schedule (ESMS): development of an instrument for the description and classification of mental health services. EPCAT Group. Acta Psychiatr Scand 2002, 405:14-23.
12. Jones P.B., Barnes T.R., Davies L., Dunn G., Lloyd H., Hayhurst K.P., et al. Randomized controlled trial of the effect on quality of life of second vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in Schizophrenia study (CUtLASS 1). Arch Gen Psychiatry 2006, 63:1079-1087.
13. Kiivet R.A., Llerena A., Dahl M.L., Rootslane L., Sánchez Vega J., Eklundh T., et al. Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden. Br J Clin Pharmacol 1995, 40(5):467-476. [Nov].
14. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373(9657):31-41.
15. Lieberman J.A., Stroup S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., et al. For the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005, 353:1209-1223.
16. Moratto E.H., Dodd S., Oderda G., Haxby D.G., Allen R., Valuck R.J. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Clin Ther 2007, 129(1):83-195.
17. National Institute for Health and Clinical Excellence (2004; NICE).
18. Paton C., Lelliott P., Harrington M., Okocha C., Sensky T., Duffett R. Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients. J Psychopharmacol 2003, 17:223-229.
19. Peacock L., Gerlach J. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices. J Clin Psychiatry 1994, 55(2):44-49.
20. Rittmannsberger H., Meise U., Schauflinger K., Horvath E., Donat H., Hinterhuber H. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999, 14:33-40.
21. Sim K., Su A., Fujii S., Yang S.Y., Chong M.Y., Ungvari G.S., et al. Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. Br J Clin Pharmacol 2004, 58:178-183.
22. Taylor D., Mace S., Mir S., Kerwin R. A prescription survey of the use of atypical antipsychotics for hospital inpatients in the United Kingdom. Int J Psychiatry Clin Pract 2000, 4:41-46.
23. Uchida N., Chong M.Y., Tan C.H., Nagai H., Tanaka M., Lee M.S., et al. International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan. Psychiatry Clin Neurosci 2007, 61:522-528.
24. Wheeler A., Kairuz T., Sheridan J., McPhee E. Sedative-hypnotic treatment in an acute psychiatric setting: comparison with best practice guidance. Pharm World Sci 2007, 29:603-610.
25. World Health Organization. The ICD-10 classification of mental and behavioral disorders. Geneva: World Health Organization; 1992.